Open Access Open Access  Restricted Access Subscription or Fee Access

Usage Pattern of Antibiotics for Management of Pneumonia

Lata Khani Bisht, Vineeth Chandy

Abstract


Abstract

Pneumonia has evolved as one of the deadly infections globally and is a cause of concern all over the world. It is an air borne infection affecting the alveoli of the lungs and is caused by virus, bacteria, fungus etc. Antibiotic therapy is the most commonly available therapy in cases of pneumonia. Hence analysis of prescribing pattern of narrow and broad-spectrum antibiotics in pneumonia patients is essential for better treatment of disease. The study also aimed at prescription pattern across different age groups namely paediatrics, adults and elderly. The patients were also analysed based on sex, smoking habits and co-morbidities. The development of drug resistant pneumonia is a cause of concern in a long run.   This study was conducted in a multi-speciality hospital among 225 patients.

 

Keywords: Antibiotic, Pneumonia, prescription pattern, respiratory tract infection, spectrum

 

Cite this Article

Lata Khani Bisht, Vineeth Chandy. Usage Pattern of Antibiotics for Management of Pneumonia. Research & Reviews: A Journal of Pharmacology. 2020; 10(2): 15–19p


Keywords


Pneumonia, antibiotic, spectrum, prescription pattern

Full Text:

PDF

References


Mizgerd JP. Acute lower respiratory tract infection. N Engl J Med 2008;358:716–727.

Wunderink RG, Mutlu GM. Pneumonia: overview and epidemiology. In: Laurent GJ, Shapiro SD, eds. Encyclopedia of Respiratory Medicine. Oxford, UK: Elsevier Academic Press; 2006:402–410.

Chalmers J, Campling J, Ellsbury G, Hawkey PM, Madhava H, Slack M. Community-acquired pneumonia in the United Kingdom: a call to action. Pneumonia. 2017;9(1):15.

Chalmers JD, Campling J, Dicker A, Woodhead M, Madhava H. A systematic review of the burden of vaccine preventable pneumococcal disease in UK adults. BMC Pulm Med. 2016;16(1):77.

Barlow G, Nathwani D, Davey P. The CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community-acquired pneumonia. Thorax. 2007;62(3):253–9.

Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Le Jeune I, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009;64(Suppl 3):iii1–55.

Chalmers JD, Mandal P, Singanayagam A, Akram AR, Choudhury G, Short PM, et al. Severity assessment tools to guide ICU admission in community-acquired pneumonia: systematic review and meta-analysis. Intensive Care Med. 2011;37(9):1409–20.

Sharma S, Sethi GR, Gupta U. Standard Treatment Guidelines: A Manual for Medical Therapeutics. 3rd ed. New Delhi: BI Publications; 2009. Delhi Society for Promotion of Rational Use of Drugs. Acute diarrhea; pp. 119–20.

Ganguly NK, Arora NK, Chandy SJ, Fairoze MN, Gill JP, Gupta U, et al. Rationalizing antibiotic use to limit antibiotic resistance in India. Indian J Med Res. 2011;134:281–94.

Bosso JA, Drew RH. Application of antimicrobial stewardship to optimise management of community acquired pneumonia. Int J Clin Pract. 2011;65:775–83.

Gupta D, Agarwal R, Aggarwal AN, Singh N, Mishra N, Khilnani GC, et al. Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations. Lung India. 2012;29(Suppl 2):S27–62.


Refbacks



Copyright (c) 2020 Research & Reviews: A Journal of Pharmacology